As filhas de Lilith: um abecedário feminino na interface dos suportes

Este artigo analisa um projeto de criação intersemiótica a partir do livro de poesia As filhas de Lilith (Rio de Janeiro: Calibán, 2009), da pernambucana Cida Pedrosa – um conjunto de 26 poemas sobre mulheres, elencadas segundo as iniciais de seus nomes, num rico abecedário que fornece um panorama arquetípico do feminino na sociedade moderna –, ilustrado pela também pernambucana Tereza Costa Rego. Em 2011, o projeto cresceu com a videoinstalação Olhares sobre Lilith, realizada por 25 diretoras que adaptaram suas leituras dos textos para filmes de curta metragem, intensificando o diálogo proposto sobre as representações da mulher pelas próprias mulheres, num número variado de suportes, resultando numa experiência única sobre temas como o corpo, os afetos e a criação dialógica na era da supremacia tecnológica sobre o humano

A Look at the Practice of Risk Classification: Integrative Review

Introduction: the increase in the number of patients in emergency services / emergency brought the need for screening / risk classification as a way to organize the urgency and emergency care in the health institutions. Objectives: know how to develop the risk classification practice in the Brazilian reality using the scientific production, the insertion of nurses in risk classification using the Brazilian scientific production. Methods: an integrative review was carried out, the data occurred during September 2015 in the following databases: Scientific Electronic Library Online (SciELO), Medical Literature Analysis and Retrieval System Online (Medline), and the Latin American and Caribbean System of Information on Health Sciences (LILACS) "GOOGLE SCHOLAR." Results: it found 9,874 articles and selected 33 for analysis. The results were organized in 04 categories: Risk classification as assistance qualifier; risk classification’s organization; operation weaknesses of the risk classification and nurse's role in risk classification. Conclusion: We conclude that the risk classification qualifies the assistance in emergency services; there are many difficulties for the risk classification’s operation and the nurse has been established as a professional with technical and legal competence to perform the risk classification. &nbsp

Quality of Life Assessment of the Wandering Emergency Service Care professionals

Introduction: the situations faced by the prehospital care professionals drive to a wear in the workplace, compromising these professionals’ quality of life. Objective: evaluate the quality of life of the professionals who work in the Wandering Emergency Service Care in three northeastern cities of Brazil from physical and environmental aspects. Methods: quantitative, descriptive and transversal study, conducted at the Wandering Emergency Service Care in the cities of Caicó, Currais Novos and Santa Cruz, located in the Rio Grande do Norte State, northeastern Brazil. The data were collected from 55 professionals in October and November 2014. Results: there was a majority of professionals aged between 25 and 29 years old, male, with high school education, income between 2 and 5 minimum wages, with other employment. The evaluation of quality of life was considered positive by most professionals. Regarding the Whoqol-Bref questionnaire there was a score variation of 65.45% to 78.76%. Conclusion: It is concluded that most of the professionals who were studied judge themselves as satisfied with their health and evaluate their quality of life positively

Thigh-length compression stockings and DVT after stroke

Controversy exists as to whether neoadjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite randomised controlled trials of more than 3000 patients. We undertook a systematic review and meta-analysis to assess the effect of such treatment on survival in patients with this disease

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19. Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospital with COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients were randomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once per day by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatment groups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment and were twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants and local study staff were not masked to the allocated treatment, but all others involved in the trial were masked to the outcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) were eligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was 65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomly allocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall, 561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days (rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median 10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days (rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, no significant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilation or death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24). Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or other prespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restricted to patients in whom there is a clear antimicrobial indication. Funding UK Research and Innovation (Medical Research Council) and National Institute of Health Research